Meet The Seven Bridges Team

With backgrounds in mathematics, genomics, computational biology, engineering, management, and beyond, our talented team is passionate about building fresh solutions to the most challenging problems in genomics and personalized medicine.

Brandi Davis-Dusenbery, Ph.D.

Chief Executive Officer

Brandi is the Chief Executive Officer of Seven Bridges. She previously served as Senior Vice President of  Product & Science and in that capacity led product strategy, managed the product organization, and oversaw the company’s largest scientific projects. Notably, she guided the creation of the first National Cancer Institute (NCI) Cancer Genomics Cloud pilot, which now supports the analytic needs of about 1,500 researchers investigating petabytes of genomic data collected in The Cancer Genome Atlas (TCGA).

Brandi is a co-chair and founding member of the Blood Profiling Atlas in Cancer project, which started as a part of Vice President Joe Biden’s Cancer Moonshot.  She leads the data working group, where she supports approximately 30 pharmaceutical and diagnostics companies, along with academic partners and regulators, in accelerating the development of safe, reliable, and accurate liquid biopsies.

Brandi is an active member of multiple professional organizations including the Common Workflow Language working group (since 2014), the International Cancer Genome Consortium (since 2015), the Pan Cancer Analysis of Whole Genomes project (since 2015), and the American Association for Cancer Research (since 2016).  Previously, she was an active member of the American Heart Association (2008-2010).

Prior to joining Seven Bridges, Brandi was a Postdoctoral research fellow in the Department of Stem Cell and Regenerative Biology at Harvard University, where she focused on uncovering differences in small RNA and protein coding RNA expression, splicing, and editing in purified human motor neurons derived from induced pluripotent stem cells from healthy controls or ALS patients.  As a graduate student at Tufts University, Brandi’s research helped explain the molecular mechanisms of vascular smooth muscle regulation by microRNAs, and lead to the identification of a novel post-transcriptional mode of microRNA regulation.

Brandi holds a Ph.D. in Biochemistry from Tufts Sackler School of Medicine and a B.S. in Biochemistry from the University of Rochester. Her work has been published in Nature, Cell, Molecular Cell and other leading journals.